EUVIMEDObjevte EUVIMED
VergleichsstudieMultizentrische StudieBeobachtungsstudieOpen access · CC BY 4.0

Efficacy and Safety of Sirolimus‐Coated Balloon Angioplasty in De Novo Lesions in Large Coronary Vessels: A Propensity Score‐Matched Study

Cecilia Gobbi, Francesco Giangiacomi iD, Guido Pasero, Andrea Faggiano, Lucia Barbieri, Gabriele Tumminello, Federico Colombo, Massimiliano Ruscica, Valentina Ardizzone, Edoardo Genta, Luca Mircoli, Stefano Galli and 1 more

Catheterization and Cardiovascular Interventions · 2025

DOI: 10.1002/ccd.31402 ↗

At a glance

Vergleichsstudie in Catheterization and Cardiovascular Interventions, 2025. Written by Cecilia Gobbi and 12 co-authors. Institution: Department of Cardio-Thoracic-Vascular Diseases, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy. Major MEDLINE topics: Angioplasty, Balloon, Coronary, Cardiac Catheters, Cardiovascular Agents, Coated Materials, Biocompatible. Cited 2 times so far (Crossref); 35 references. The full text is freely available (open access, CC BY 4.0).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background

Evidence regarding drug‐coated balloon (DCB)‐only angioplasty in de novo lesions of large vessels is still limited and mainly focused on paclitaxel‐coated balloon. We aimed to analyze the safety and efficacy of sirolimus‐coated balloon (SCB)‐only angioplasty in de novo lesions in large vessels compared to drug‐eluting stent (DES).

Methods

In this retrospective, dual‐center, case‐control study, we enrolled all consecutive patients treated between January 2022 and January 2024 with SCB‐only angioplasty in de novo lesion in large vessel (> 2.75 mm) compared to a propensity‐score matched contemporary population treated with DES. The primary endpoint was the rate of target lesion revascularization (TLR), while secondary endpoints were cardiac death (CD), target vessel revascularization (TVR), myocardial infarction (MI), and target lesion failure (TLF), defined as a composite of them.

Results

The mean age was 70.1 ± 9.8 years in the SCB group ( n = 92) and 67.9 ± 9.6 years in the DES group ( n = 92) ( p = 0.76). The median follow‐up was 19.5 ± 12 months in the SCB group and 20.1 ± 13.1 months in the DES group ( p = 0.47). TLR occurred in 6.7% of patients in the SCB group and 5.6% in the DES group ( p = 0.75). The incidence of MI, TVR, and TLF were similar between the two groups (4.3% vs 3.3%, p = 0.7, 2.2% vs 3.4%, p = 0.65% and 9.8% vs 8.7%, p = 0.79). CD occurred in 4.3% in the SCB group, compared to 3.3% in the DES group ( p = 0.70).

Conclusion

Our study suggests that SCB angioplasty is both safe and effective in the treatment of de novo lesions of large vessels compared with DES.

Subjects

MeSH terms (MEDLINE)

Angioplasty, Balloon, CoronaryCardiac CathetersCardiovascular AgentsCoated Materials, BiocompatibleCoronary Artery DiseaseSirolimusAgedFemaleHumansMaleMiddle AgedDrug-Eluting StentsPropensity ScoreRetrospective StudiesRisk AssessmentRisk FactorsTime FactorsTreatment Outcome

Author keywords

drug‐coated balloonsirolimus‐coated balloontarget lesion revascularization

Substances

Cardiovascular AgentsCoated Materials, BiocompatibleSirolimus

Authors and institutions

  • Department of Cardio-Thoracic-Vascular Diseases, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
  • Department of Interventional Cardiology, Centro Cardiologico Monzino IRCCS, Milan, Italy.

ORCID profiles: Francesco Giangiacomi

Cite

APA

Gobbi, C., Giangiacomi, F., Pasero, G., Faggiano, A., Barbieri, L., Tumminello, G., Colombo, F., Ruscica, M., Ardizzone, V., Genta, E., Mircoli, L., Galli, S., & Carugo, S. (2025). Efficacy and Safety of Sirolimus‐Coated Balloon Angioplasty in De Novo Lesions in Large Coronary Vessels: A Propensity Score‐Matched Study. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.31402

Vancouver

Gobbi C, Giangiacomi F, Pasero G, Faggiano A, Barbieri L, Tumminello G, et al. Efficacy and Safety of Sirolimus‐Coated Balloon Angioplasty in De Novo Lesions in Large Coronary Vessels: A Propensity Score‐Matched Study. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.31402

BibTeX
@article{Gobbi2025,
  author = {Gobbi, Cecilia and Giangiacomi, Francesco and Pasero, Guido and Faggiano, Andrea and Barbieri, Lucia and Tumminello, Gabriele and Colombo, Federico and Ruscica, Massimiliano and Ardizzone, Valentina and Genta, Edoardo and Mircoli, Luca and Galli, Stefano and Carugo, Stefano},
  title = {Efficacy and Safety of Sirolimus‐Coated Balloon Angioplasty in De Novo Lesions in Large Coronary Vessels: A Propensity Score‐Matched Study},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2025},
  doi = {10.1002/ccd.31402}
}
Start for free →